The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Genzyme; Heron; Regeneron; Squibb
Speakers' Bureau - Genzyme; Regeneron; Squibb
Research Funding - Novartis (Inst); Regeneron (Inst)
Toxicity and outcomes of ipilimumab plus nivolumab in patients 80 years and older.
 
Haley M Meyer
No Relationships to Disclose
 
Christopher Dodoo
No Relationships to Disclose
 
Daniel Walden
No Relationships to Disclose
 
Thai Huu Ho
No Relationships to Disclose
 
Nathan Y Yu
No Relationships to Disclose
 
Panos Savvides
No Relationships to Disclose
 
Aaron Scott Mansfield
Honoraria - Roche
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen (Inst)
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
Other Relationship - Mesothelioma Applied Research Foundation
 
Konstantinos Leventakos
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Mirati Therapeutics (Inst); MJH Life Sciences (Inst); OncLive (Inst); Regeneron (Inst); Takeda (Inst); Targeted Oncology (Inst)
Research Funding - AstraZeneca (Inst); Mirati Therapeutics (Inst)
 
Kaushal Parikh
Consulting or Advisory Role - Guardant Health; Jazz Pharmaceuticals (Inst); MJH Life Sciences
Research Funding - Pfizer
 
Anastasios Dimou
Honoraria - Intellisphere; Intellisphere (Inst); Intellisphere (Inst); Roche/Genentech
Consulting or Advisory Role - Anheart Therapeutics; ChromaCode; Guardant Health (Inst); TP Therapeutics (Inst)
Research Funding - Anheart Therapeutics (Inst); Anheart Therapeutics (Inst); Guardant Health; Merck; Novartis (Inst); Sorrento Therapeutics (Inst); Sorrento Therapeutics (Inst); Syntrix Biosystems (Inst)
Travel, Accommodations, Expenses - Guardant Health
Other Relationship - Rising Tide Foundation (Inst)
 
Yanyan Lou
Consulting or Advisory Role - AstraZeneca; Janssen; Lilly; Turning Point Therapeutics
Research Funding - Blueprint Medicines (Inst); Daiichi-Sankyo (Inst); Genmab (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Tolero Pharmaceuticals (Inst)
 
Rami Manochakian
Stock and Other Ownership Interests - Alpha 2
Consulting or Advisory Role - Alpha 2; AstraZeneca; Cardinal Health; Guardant Health; Janssen; Novocure; Takeda; Turning Point Therapeutics
 
Vinicius Ernani
Consulting or Advisory Role - AstraZeneca/MedImmune; Daiichi Sankyo/Astra Zeneca; Jazz Pharmaceuticals; Novocure
Research Funding - AstraZeneca/MedImmune